Provider review, September 2026
Defy Medical publishes its company name, its governing law and a vendor-disclosure page, and names exactly one of the compounds this site tracks on its peptide page. The disclosure is unusually good; the peptide catalogue behind it is not on the page that describes it.
Defy Medical does not publish a price today.
Defy Medical also sells 1 compound this site boards without publishing a price for it: Sermorelin.
Defy Medical is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Its terms name the operating company in the first line and repeat it throughout, including in the liability clauses where it matters most.
They also name a single state's law as governing, without the split between governing law and venue that several sellers here publish.
Separately it links a vendor-information page from its own footer, which is a disclosure surface almost nothing else in this comparison has.
For a reader trying to find out who they are contracting with, this is among the clearer answers on the roster.
The peptide service page names one compound this site follows and otherwise discusses the category in general terms.
A sub-page for that compound, tried directly, returned not-found, so the per-compound records are not where the address pattern suggests.
The catalogue is therefore somewhere this pass did not reach, and this row says so rather than inferring its contents.
What is declared here is what was read, which is one compound.
The peptide page carries no figure, and the only figures in the terms are a processing charge and a liability cap.
Nothing here claims third-party testing, so there is no claim to check and no document to fail to find.
Publishing a figure somewhere on its own site is true of one hundred and thirty-seven of the two hundred and ten sellers here, so it separates far fewer of them than a reader expects.
The host itself was checked in the same pass as everything above: a first control returned a server error, which proves nothing either way; a second control at a different nonsense path on the same host returned 404, and that is the one this row relies on, which is what any absence recorded here rests on.
One hundred and seventy-six of the two hundred and ten sellers here publish no state list at all, and this is one of them, so eligibility is settled inside an intake rather than before one.
Sixteen of the two hundred and ten sellers here name the facility that fills an order; this is one of the one hundred and ninety-four that do not, so there is no facility a reader can look up.
Four of the two hundred and ten sellers here describe lab work as included in what they charge, and this is not one of them.
It declares one of the sixteen compounds this site tracks, which puts it with the twenty-nine single-compound sellers here — anything else in this comparison has to be bought somewhere else.
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.
Auren Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Auren RxIts terms name a single limited liability company and repeat it throughout, and state that the contract is governed solely by one state's law.
No. The peptide page carries no figure and the terms' two figures are a processing charge and a liability cap.
Because one is what the peptide service page names. A per-compound sub-page tried directly returned not-found, so the rest of the catalogue was not reached and is not guessed at here.
No list is published, though the terms name one state's law as governing.
A disclosure page it links from its own footer. Very little else in this comparison publishes one.
Defy Medical is not a paid partner; this link may earn a commission if that changes. Full disclosure.